和元生物股东计划减持最多2071万股

财中社11-28

财中社11月28日电和元生物（688238）发布股东减持股份计划公告。公告显示，股东上海檀英及其一致行动人拟通过集中竞价和大宗交易的方式减持最多1424万股，占公司总股本的2.2%。此外，股东华睿盛银及其一致行动人也计划减持不超过647万股，占总股本的1%。减持计划自公告披露之日起15个交易日后的3个月内进行。截至公告披露日，上海檀英持有公司股份3075万股，占总股本的4.7498%；华睿盛银持有...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2486638723?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-28 08:29","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2486638723","market":"sh","top_or_hot":-1,"title":"和元生物股东计划减持最多2071万股","media":"财中社","content":"<div>\n<p>财中社11月28日电和元生物（688238）发布股东减持股份计划公告。公告显示，股东上海檀英及其一致行动人拟通过集中竞价和大宗交易的方式减持最多1424万股，占公司总股本的2.2%。此外，股东华睿盛银及其一致行动人也计划减持不超过647万股，占总股本的1%。减持计划自公告披露之日起15个交易日后的3个月内进行。截至公告披露日，上海檀英持有公司股份3075万股，占总股本的4.7498%；华睿盛银持有...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128083400a25af176&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>和元生物股东计划减持最多2071万股</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n和元生物股东计划减持最多2071万股\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-28 08:29 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128083400a25af176&s=b><strong>财中社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>财中社11月28日电和元生物（688238）发布股东减持股份计划公告。公告显示，股东上海檀英及其一致行动人拟通过集中竞价和大宗交易的方式减持最多1424万股，占公司总股本的2.2%。此外，股东华睿盛银及其一致行动人也计划减持不超过647万股，占总股本的1%。减持计划自公告披露之日起15个交易日后的3个月内进行。截至公告披露日，上海檀英持有公司股份3075万股，占总股本的4.7498%；华睿盛银持有...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128083400a25af176&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688238","symbol_name":"和元生物","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128083400a25af176&s=b","article_id":"2486638723","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128083400a25af176&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2486638723","pubTimestamp":1732753740,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"公告显示，股东上海檀英及其一致行动人拟通过集中竞价和大宗交易的方式减持最多1424万股，占公司总股本的2.2%。此外，股东华睿盛银及其一致行动人也计划减持不超过647万股，占总股本的1%。减持计划自公告披露之日起15个交易日后的3个月内进行。截至公告披露日，上海檀英持有公司股份3075万股，占总股本的4.7498%；华睿盛银持有1967万股，占总股本的3.0385%。此次减持主要是由于股东资金需求及基金存续期即将到期。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688238":"和元生物","BK0216":"研究试验"},"translate_title":"Heyuan Biotech shareholders plan to reduce their holdings by up to 20.71 million shares","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688238":1},"content_text":"财中社11月28日电和元生物（688238）发布股东减持股份计划公告。公告显示，股东上海檀英及其一致行动人拟通过集中竞价和大宗交易的方式减持最多1424万股，占公司总股本的2.2%。此外，股东华睿盛银及其一致行动人也计划减持不超过647万股，占总股本的1%。减持计划自公告披露之日起15个交易日后的3个月内进行。截至公告披露日，上海檀英持有公司股份3075万股，占总股本的4.7498%；华睿盛银持有1967万股，占总股本的3.0385%。此次减持主要是由于股东资金需求及基金存续期即将到期。减持计划不会对公司的治理结构和持续经营产生重大影响。2024年前三季度，和元生物实现收入1.84亿元，归母净利润-1.90亿元。（文章来源：财中社）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2486638723"}